Another Monkeypox case in the UK

On Tuesday December 3rd a patient was admitted to a specialist unit at St Thomas' Hospital in central London after Public Health England confirmed a diagnosis of Monkeypox. 

It is believed the individual contracted the virus whilst visting Nigeria, which has seen at least four

...

Pneumonic Plague Diagnosed in Beijing

Two people have been diagnosed with Pneumonic Plague in Beijing’s Chaoyang district, both are currently in an unamed hospital and receiving treament. 

Chaoyang Hospital, where the two patients were initially treated, has taken the measure of replacing all the chairs at its

...

Merck's Ebola Vaccine Granted Conditional Approval in the EU

Merck , known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola

...

GSK agrees to divest rabies and tick-borne encephalitis vaccines to Bavarian Nordic

GlaxoSmithKline plc has announced the divestment of travel vaccines Rabipur (tradename Rabavert in the US) for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic.

The decision to divest these brands, acquired from Novartis in 2015 as

...

FDA Clears First Rapid Diagnostic Test for Ebola

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on Thursday allowed the marketing of the first rapid diagnostic test for the Ebola virus that has not been authorized via the agency’s Emergency Use Authorization (EUA) pathway.
...

Ebola Therapy mAb114 Receives $14 million in Funding

It was annonuced on September 24th that the Biomedical Advanced Research and Development Authority (BARDA) intends to provide $14 millio, as well as expertise support for the advanced development of an investigational Ebola treatment being pursued by Ridgeback Biotherapeutics of

...

FDA Approve Smallpox/Monkeypox Vaccine

The FDA has approved the Jynneos vaccine by Bavarian Nordic for the prevention of Smallpox and Monkeypox in adults 18 years of age and older determined to be at high risk for these infections.

Jynneos is a live vaccine produced from the strain Modified Vaccinia Ankara-Bavarian Nordic

...

Biofactura Awarded $67.4 Million to Develop Smallpox Biodefense Therapeutic

BioFactura, Inc. announced on September 26th a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $67.4 million for the advanced development of its Smallpox Biodefense Therapeutic as a potential medical countermeasure (MCM) for the treatment

...

Bertin Announce 2 Newcomers for Biological Threat Sampling

Bertin’s teams are proud to announce the release of 2 new air sampling equipment for biological air monitoring or biological recognition missions:

– The Coriolis Compact: dry cyclonic collector intended for air monitoring in a biological threat context.

– The Coriolis Nano:

...

Explosion at VECTOR Laboratory

Monday, September 16th, saw reports emerge of an explosion at the Russian State Research Center of Virology and Biotechnology, known as Vector.

Ebola Bombali Detected in Guinea

Researchers from The University of California, Davis, have recenctly publsihed their findings regarding the discovery of the sitxth ebolavirus, Bombali, in Angolan free-tailed bats roosting inside people’s houses in Guéckedou and Kissidougou, Guinea. 

The team from UC

...

Defence Minister calls Bioterrorism a Contagious Plague

Speaking at the Shanghai Cooperation Organisation's (SCO) First Military Medicine Conference this week, India's Defence Minister Rajnath Singh referred to bioterrorism as a 'contagious plague', and called upon the Armed Forces Medical Services (AFMS) of the SCO countries to

...

Man Pleads Guilty to Ricin Plot

A man from Los Angeles pleaded guilty this week to Federal charges of attempting to obtain ricin for unlawful purposes, namely to poison his wife!

Over a two-month period late last year, Steve S. Kim attempted to obtain ricin from what he thought was an online seller, but in fact was an

...

Tearaway Tularemia

UPDATE: Case numbers have now reached over 800. 

Sweden is continuing to see an increase in the number of people affected by Tularemia this year.

At present there have been around 700 cases reported, and we are only just entering September. This is a much higher number than

...

HHS Purchases Additional Smallpox Vaccine for SNS

The U.S. Department of Health and Human Services (HHS) announced this week that they will be purchasing a smallpox vaccine, called ACAM2000, to build and replenish vaccine stored in the ...

HHS Funds an Additional Year of Ebola Vaccine Manufacturing

As part of the international response to the Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and to meet domestic biodefense goals, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will support

...

CDC Shuts Down USAMRIID Lab

Following an inspection in June, the CDC has issued a cease-and-desist order to the Fort Detrick biodefense lab. All research at the lab, run by the Army Medical Research Institute of Infectious Diseases (USAMRIID), is now on hold until further notice. 

The cease-and-desist

...

GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study

GeoVax Labs, Inc.has announced positive results (100% protection) from preclinical challenge studies of its Marburg virus vaccine candidate; Marburg virus a critical medical threat against which there is currently no available vaccine or treatment. This study data adds to that showing similar

...

Biology professor receives $1.9 million grant from NIH to study Vaccinia virus

Zhilong Yang, an assistant professor in the Division of Biology, is the principal investigator on a new, nearly $1.9 million grant from the National Institutes of Health. The five-year project will study how vaccinia virus — a member of the poxvirus family — produces its proteins. This award is

...

DARPA Awards Grant to ASU for Fight Against WMDs

Arizona State University has announced that it has been selected by the U.S. Defense Advanced Research Projects Agency (DARPA) to build a field-deployable, point-of-care device that will determine in 30 minutes or less if a person has been exposed to weapons of mass destruction or

...

Ebola Outbreak 2018 - Present Health Information Guide

In response to the WHO declaring the Ebola outbreak in the DRC a Public Health Emergency of International Concern (PHEIC), the U.S. National Library of Medicine has made available to all the Ebola Outbreak: 2018-Present Health Information Guide. 

The guide can be found ...

Don’t Blow It! Phase 2 Launch Event.

DASA is inviting expressions of interest for a launch event on 1 October 2019 for our 'Don’t Blow It! Safely eliminating chemical and biological munitions on the battlefield' competition.

This ...

SIGA Awarded DOD Contract for Development of TPOXX as PEP for Smallpox

SIGA Technologies announced today that they have been awarded a multi-year contract by the U.S. Department of Defense (DOD) to support the work necessary to gain a potential label expansion for TPOXX that would include its use for post-exposure prophylaxis (PEP) for Smallpox.

The

...

USAID Pledges $98 Million in Support for Ebola Outbreak

On July 2nd the United States Agency for International Development (USAID) announced they would be giving $98 million to the Democratic Republic of Congo (DRC) to assist in the fight against the current Ebola outbreak. 

"With this funding, USAID is providing lifesaving assistance,

...

Russian Federation, Uzbekistan Security Council Agree to Cooperate on Biosecurity

As reported by Interfax: 

The Russian Federation Security Council press secretary, Yevgeniy Anoshin, informed journalists that the secretary of the Russian Security Council, Nikolay Patrushev, and his counterpart from Uzbekistan, Viktor Makhmudov, signed a memorandum in Ufa on

...

FBI investigates as Ricin scare prompts evacuation

The FBI is investigating the circumstances around an evacuation at a University of Minnesota apartment building this week due to reports of Ricin.

It was reported by CBS Minnesota that a student who lived in the complex called 911 on Tuesday, May 7th, saying she had eaten Ricin,

...

Zeteo Tech Awarded $6.5M DHS S&T Contract

Zeteo Tech, the biodefense and medical device company that has developed a revolutionary new class of fieldable biological mass spectrometers, today announced that it has been awarded a contract of up to $6.5 million (including options) from the U.S. Department of Homeland Security (DHS) to

...

Ology Bioservices Wins Two DOD Awards Totalling More Than $135 Million

Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two contracts

...

UAMS researcher gets $1.86M to study poxvirus

The poxvirus — with its applications for the investigation of disease development, cross-species infection-caused diseases, vaccine development and cancer virotherapy — is the focus of research by Jia Liu, Ph.D., who has received a $1.86 million grant from the National Institutes of Health to

...

Emergent BioSolutions bags contract worth up to $100 million

Emergent BioSolutions Inc. has announced that it has signed an indefinite-delivery, indefinite-quantity (IDIQ) contract with the U.S. Department of State to establish a long-term, reliable, and stable supply chain for medical countermeasures that address chemical warfare agents. The

...

Tularemia bacterium hibernates and can be traced in terror attacks

According to a new doctoral thesis at Umeå University, Francisella tularensis, the bacterium that causes tularemia, can survive in a dormant state for long periods before causing a new outbreak. The thesis also proposes a method for tracing the bacterium if it is used as a biological

...

CEPI awards US$ 34M contract to CureVac to advance The RNA Printer

It was announced today that the Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac AG, a biopharmaceutical company pioneering the field of mRNA-based vaccines, have announced a partnership agreement worth up to US$ 34 million for the ongoing development of The RNA Printer

...

Our Current Sponsors